Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung

被引：0
作者：
G McLachlan
H Davidson
E Holder
L A Davies
I A Pringle
S G Sumner-Jones
A Baker
P Tennant
C Gordon
C Vrettou
R Blundell
L Hyndman
B Stevenson
A Wilson
A Doherty
D J Shaw
R L Coles
H Painter
S H Cheng
R K Scheule
J C Davies
J A Innes
S C Hyde
U Griesenbach
E W F W Alton
A C Boyd
D J Porteous
D R Gill
D D S Collie
机构：
[1] The Roslin Institute and R(D)SVS,Developmental Biology Division
[2] EBVC,Nuffield Department of Clinical Laboratory Sciences
[3] University of Edinburgh,Department of Veterinary Pathology
[4] Medical Genetics Section,Department of Gene Therapy
[5] School of Molecular and Clinical Medicine,undefined
[6] University of Edinburgh,undefined
[7] Western General Hospital,undefined
[8] Gene Medicine Group,undefined
[9] University of Oxford,undefined
[10] John Radcliffe Hospital,undefined
[11] College of Medicine and Veterinary Medicine,undefined
[12] University of Edinburgh,undefined
[13] Genzyme Corporation,undefined
[14] Faculty of Medicine,undefined
[15] Imperial College London,undefined
来源：
Gene Therapy | 2011年 / 18卷
关键词：
gene delivery; lung; non-viral; sheep; cystic fibrosis; aerosol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We use both large and small animal models in our pre-clinical evaluation of gene transfer agents (GTAs) for cystic fibrosis (CF) gene therapy. Here, we report the use of a large animal model to assess three non-viral GTAs: 25 kDa-branched polyethyleneimine (PEI), the cationic liposome (GL67A) and compacted DNA nanoparticle formulated with polyethylene glycol-substituted lysine 30-mer. GTAs complexed with plasmids expressing human cystic fibrosis transmembrane conductance regulator (CFTR) complementary DNA were administered to the sheep lung (n=8 per group) by aerosol. All GTAs gave evidence of gene transfer and expression 1 day after treatment. Vector-derived mRNA was expressed in lung tissues, including epithelial cell-enriched bronchial brushing samples, with median group values reaching 1–10% of endogenous CFTR mRNA levels. GL67A gave the highest levels of expression. Human CFTR protein was detected in small airway epithelial cells in some animals treated with GL67A (two out of eight) and PEI (one out of eight). Bronchoalveolar lavage neutrophilia, lung histology and elevated serum haptoglobin levels indicated that gene delivery was associated with mild local and systemic inflammation. Our conclusion was that GL67A was the best non-viral GTA currently available for aerosol delivery to the sheep lung, led to the selection of GL67A as our lead GTA for clinical trials in CF patients.
引用
收藏
页码：996 / 1005
页数：9
相关论文
共 189 条
[1]  
Griesenbach U(2009)Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy Adv Drug Deliv Rev 61 128-139
[2]  
Alton EWFW(1993)Correction of the ion-transport defect in cystic-fibrosis transgenic mice by gene-therapy Nature 362 250-255
[3]  
Hyde SC(1996)Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR/DOTAP Gene Ther 3 1113-1123
[4]  
Gill DR(1993)Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice Nat Genet 5 135-142
[5]  
Higgins CF(2008)Production of CFTR-null and CFTR-Delta F508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer J Clin Invest 118 1571-1577
[6]  
Trezise AEO(2008)Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets J Clin Invest 118 1578-1583
[7]  
MacVinish LJ(2010)Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth Sci Transl Med 2 29ra31-653
[8]  
Cuthbert AW(2003)Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments Mol Ther 8 646-354
[9]  
McLachlan G(2007)Optimizing aerosol gene delivery and expression in the ovine lung Mol Ther 15 348-1290
[10]  
Ho L-H(2008)Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes Mol Ther 16 1283-54
12345678910